10 Unrivaled Penny Stocks to Buy Now
In this article, we will discuss 10 Unrivaled Penny Stocks to Buy Now.
X4 Pharmaceuticals Inc (XFOR)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Perceptive Advisors Joseph Edelman | 7,933,491 | $37,049,403 | +18% | 0.56% |
| 2. | Saturn V Capital Management Xiaoying Tian | 6,973,343 | $32,565,512 | +9% | 4.67% |
| 3. | Deep Track Capital David Kroin | 5,878,757 | $27,453,795 | -8% | 0.4% |
| 4. | Kalehua Capital Management Tai-Li Chang | 3,722,840 | $17,385,663 | 9.99% | |
| 5. | Braidwell LP Alex Karnal | 2,922,754 | $13,649,261 | -11% | 0.5% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.58 | 4,600 | $11,883.64 | 333,251 | 2026-10-16 | Filing | |
| $2.90 | 86,206 | $249,997.40 | 376,087 | 2025-10-23 | Filing | |
| $2.48 | 1,032 | $2,561.42 | 25,337 | 2025-05-16 | Filing | |
| $0.34 | 13,404 | $4,597.57 | 129,173 | 2024-11-15 | Filing | |
| $0.68 | 21,646 | $14,654.34 | 115,769 | 2024-05-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.86 | 11,767 | $33,658.33 | 155,983 | 2026-10-01 | Filing | |
| $4.44 | 24,576 | $109,228.03 | 265,305 | 2026-08-12 | Filing | |
| $4.44 | 47,436 | $210,829.30 | 328,651 | 2026-08-12 | Filing | |
| $4.26 | 8,543 | $36,428.21 | 167,750 | 2026-06-30 | Filing | |
| $4.29 | 16,961 | $72,820.36 | 176,293 | 2026-05-12 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 10,000 | $29,000 | 0% | |
| 2. | 789 | $2,288 | 0% | |
| 3. | 385 | $1,117 | 0% | |
| 4. | 284 | $824 | 0% | |
| 5. | 1 | $3 | 0% |
News See All
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q1 2025 Earnings Call Transcript
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q1 2025 Earnings Call Transcript May 1, 2025X4 Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $4.0E-5, expectations were $-4.13.
Why These 15 Healthcare Stocks Are Surging in 2025
After lagging behind the broader market in 2024, many healthcare stocks are making a comeback this year.
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q4 2024 Earnings Call Transcript
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q4 2024 Earnings Call Transcript March 25, 2025X4 Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.2 EPS, expectations were $-0.17.
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q3 2024 Earnings Call Transcript
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Greetings, and welcome to the X4 Pharmaceuticals Call and Webcast.
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q1 2024 Earnings Call Transcript
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q1 2024 Earnings Call Transcript May 7, 2024 X4 Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.25884 EPS, expectations were $-0.17.
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q4 2023 Earnings Call Transcript
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q4 2023 Earnings Call Transcript March 21, 2024 X4 Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.15.
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q3 2023 Earnings Call Transcript
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q3 2023 Earnings Call Transcript November 9, 2023 X4 Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.15.
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q2 2023 Earnings Call Transcript
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q2 2023 Earnings Call Transcript August 10, 2023 X4 Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.33 EPS, expectations were $-0.17.
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q1 2023 Earnings Call Transcript
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q1 2023 Earnings Call Transcript May 6, 2023 Operator: Greetings, and welcome to X4 Pharmaceuticals' First Quarter 2023 Earnings Conference Call.